✦ LIBER ✦

ChemInform Abstract: New Histamine H3-Receptor Ligands of the Proxifan Series: Imoproxifan and Other Selective Antagonists with High Oral in vivo Potency.

✍ Scribed by Holger Stark; et al. et al.

Publisher: John Wiley and Sons
Year: 2000
Weight: 31 KB
Volume: 31
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200051123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Development of FUB

ChemInform Abstract: Development of FUB 181, a Selective Histamine H3-Receptor Antagonist of High Oral in vivo Potency with 4-(ω-(Arylalkyloxy)alkyl)-1H-imidazole Structure.

✍ H. STARK; A. HUELS; X. LIGNEAU; K. PURAND; H. PERTZ; J.-M. ARRANG; J.-C. SCHWART 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 1 views

Development of FUB 181, a Selective Hist

Development of FUB 181, a Selective Histamine H3-Receptor Antagonist of High Oral in Vivo Potency with 4-(?gv-(Arylalkyloxy)alkyl)-1H-imidazole Structure

✍ Holger Stark; Annette Hüls; Xavier Ligneau; Katja Purand; Heinz Pertz; Jean-Mich 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of trans-N-[4- [2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl] -4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat.

✍ Geoffrey Stemp; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 1 views